FdaApplication
ANDA 204012
Identifiers
- fda_app_no: ANDA204012
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2019-09-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMEPRAZOLE | OMEPRAZOLE | 10MG | CAPSULE, DELAYED REL PELLETS;ORAL |
| OMEPRAZOLE | OMEPRAZOLE | 20MG | CAPSULE, DELAYED REL PELLETS;ORAL |
2 products